Thienopyrimidines of the formula (I) and their physiologically acceptable salts, in which R
1
, R
2
and X are as defined in claim 1, exhibit phosphodiesterase V inhibition and can be employed for the treatment of illnesses of the cardiovascular system and for the treatment and/or therapy of impotence.
1